NASDAQ:VYGR

Voyager Therapeutics Stock Is Waking Up Before a Make-or-Break Tau Window

Voyager Therapeutics Stock Is Waking Up Before a Make-or-Break Tau Window

Voyager Therapeutics shares rose 4 cents to $3.83 in thin premarket trading, valuing the company at $228 million. H.C. Wainwright reiterated a Buy rating and $25 target, citing upcoming milestones including first human dosing for VY1706 and tau PET imaging data for VY7523 in the second half of 2026. Voyager reported $171.7 million in cash at the end of Q1.
May 27, 2026

Stock Market Today

  • ANZ Bank Shares Steady Amid Investor Focus on Banking Sector Trends
    June 1, 2026, 9:09 PM EDT. ANZ Bank shares remained steady as investors closely monitor emerging trends in the banking sector. Market participants are assessing economic indicators and regulatory developments impacting financial institutions. ANZ's stock stability reflects cautious investor sentiment amid evolving sector dynamics, including interest rate shifts and credit conditions. This cautious stance underscores broader uncertainty in banking markets as stakeholders evaluate growth prospects and risk factors. Analysts suggest that maintaining current positions may signal investor confidence in ANZ's resilience despite sector-wide fluctuations. The banking industry continues to navigate challenges from market volatility and policy changes, making investor reactions to such trends crucial for future performance forecasts.